(Q36593770)

15 August 2017

1 reference

title

A vision of cell death: Fas ligand and immune privilege 10 years later (English)

1 reference

15 August 2017

1 reference

Thomas A Ferguson

1

1 reference

PubMed ID

16972907

15 August 2017

Thomas S Griffith

series ordinal

2

1 reference

15 August 2017

1 October 2006

1 reference

15 August 2017

Immunological Reviews

1 reference

15 August 2017

213

1 reference

15 August 2017

228-238

1 reference

CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Apoptosis, tolerance, and regulatory T cells--old wine, new wineskins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Activation-induced cell death in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

A vision of cell death: insights into immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Enhanced and accelerated lymphoproliferation in Fas-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Tumor counterattack: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Regulation of the proinflammatory effects of Fas ligand (CD95L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Regulation of Fas ligand-induced apoptosis by TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Fas ligand but not complement is critical for control of experimental Staphylococcus aureus Endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

The role of Fas-FasL in the development and treatment of ischemic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA/2J pigmentary glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Projection of an immunological self shadow within the thymus by the aire protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Induction of anterior chamber-associated immune deviation requires an intact, functional spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Antigen from the anterior chamber of the eye travels in a soluble form to secondary lymphoid organs via lymphatic and vascular routes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Fas and Fas Ligand Expressed on Cells of the Immune System, not on the Target Tissue, Control Induction of Experimental Autoimmune Uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

Dual Immunological Unresponsiveness Induced by Cell Membrane Coupled Hapten or Antigen*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00430.X

10.1111/J.1600-065X.2006.00430.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16972907